---
title: Safety and effectiveness of Janus kinase inhibitors in the management of inflammatory
  bowel disease following liver transplantation
date: '2024-03-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38502366/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240320180609&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: As the largest case series to-date, these data indicate
  that combining JAK inhibition with transplant anti-rejection medication may be a
  safe and clinically effective method of treating IBD in patients with prior biologic
  ...'
disable_comments: true
---
CONCLUSIONS: As the largest case series to-date, these data indicate that combining JAK inhibition with transplant anti-rejection medication may be a safe and clinically effective method of treating IBD in patients with prior biologic ...